Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 1865318)

Published in Am J Pathol on August 01, 1996

Authors

T Knittel1, S Aurisch, K Neubauer, S Eichhorst, G Ramadori

Author Affiliations

1: Department of Internal Medicine, University of Göttingen, Germany.

Articles citing this

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28

The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch (1997) 1.54

Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol (2005) 1.22

Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol (1999) 1.18

Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11

Myofibroblasts: paracrine cells important in health and disease. Trans Am Clin Climatol Assoc (2000) 0.97

Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol (2007) 0.93

Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis. Gut (2006) 0.90

Immunohistochemical analysis of development of desmin-positive hepatic stellate cells in mouse liver. J Anat (2000) 0.90

Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells. Cell Tissue Res (2009) 0.89

Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture. Am J Pathol (1999) 0.89

Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One (2014) 0.87

Expression of cellular prion protein in activated hepatic stellate cells. Am J Pathol (1998) 0.86

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis. Front Pharmacol (2016) 0.86

Immunohistochemical detection of polyductin and co-localization with liver progenitor cell markers during normal and abnormal development of the intrahepatic biliary system and in adult hepatobiliary carcinomas. J Cell Mol Med (2008) 0.85

Vinculin: a novel marker for quiescent and activated hepatic stellate cells in human and rat livers. Virchows Arch (2003) 0.83

Irradiation leads to apoptosis of Kupffer cells by a Hsp27-dependant pathway followed by release of TNF-alpha. Radiat Environ Biophys (2008) 0.82

Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair. Cell Cycle (2011) 0.82

Neural cell adhesion molecule and polysialic acid in ductular reaction: the puzzle is far from completed, but the picture is becoming more clear. Hepatology (2014) 0.79

Up-regulation of uPARAP/Endo180 during culture activation of rat hepatic stellate cells and its presence in hepatic stellate cell lines from different species. BMC Cell Biol (2009) 0.79

SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules. Am J Pathol (2010) 0.76

Selective α1B- and α1D-adrenoceptor antagonists suppress noradrenaline-induced activation, proliferation and ECM secretion of rat hepatic stellate cells in vitro. Acta Pharmacol Sin (2014) 0.76

Simple Shared Motifs (SSM) in conserved region of promoters: a new approach to identify co-regulation patterns. BMC Bioinformatics (2011) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71

A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98

The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology (1985) 7.77

Cell adhesion molecules: implications for a molecular histology. Annu Rev Biochem (1991) 2.86

Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest (1990) 2.61

The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res (1984) 2.57

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol (1989) 2.47

Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med (1989) 2.17

Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res (1989) 2.07

The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol (1994) 1.83

Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1990) 1.83

Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology (1992) 1.78

The nucleotide sequence of a rat vascular smooth muscle alpha-actin cDNA. Nucleic Acids Res (1988) 1.56

Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol (1991) 1.55

The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 1.49

Regulation of muscle differentiation: cloning of sequences from alpha-actin messenger ribonucleic acid. Biochemistry (1980) 1.48

Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol (1994) 1.44

Enhanced myogenesis in NCAM-transfected mouse myoblasts. Nature (1990) 1.39

Identification of a cDNA clone that contains the complete coding sequence for a 140-kD rat NCAM polypeptide. J Cell Biol (1987) 1.38

Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology (1995) 1.32

Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28

Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther (1995) 1.26

Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidney. Kidney Int (1993) 1.26

Molecular characterization of eukaryotic polysialyltransferase-1. Nature (1995) 1.25

Identification of a heparin binding domain of the neural cell adhesion molecule N-CAM using synthetic peptides. Neuron (1989) 1.23

Characterization of desmin-positive rat liver sinusoidal cells. Hepatology (1987) 1.23

At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during rat heart development. Mol Cell Biol (1991) 1.20

Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J Hepatol (1987) 1.17

Different extracellular domains of the neural cell adhesion molecule (N-CAM) are involved in different functions. J Cell Biol (1992) 1.08

Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol (1993) 1.05

Modulation of NCAM expression by transforming growth factor-beta, serum, and autocrine factors. J Cell Biol (1990) 1.05

N-CAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res (1994) 1.04

Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas. Mol Endocrinol (1992) 1.01

Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology (1992) 0.99

Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol (1991) 0.99

Changes in neural cell adhesion molecule (NCAM) structure during vertebrate neural development. Proc Natl Acad Sci U S A (1987) 0.98

Cell adhesion molecules as morphoregulators. Curr Opin Cell Biol (1995) 0.98

The neural cell adhesion molecule (N-CAM) inhibits proliferation in primary cultures of rat astrocytes. Proc Natl Acad Sci U S A (1995) 0.94

Neural cell adhesion molecule (N-CAM) inhibits astrocyte proliferation after injury to different regions of the adult rat brain. Proc Natl Acad Sci U S A (1995) 0.92

Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons. J Cell Biol (1994) 0.91

Binding properties of mechanically and enzymatically isolated hepatocytes for IgG and C3. Liver (1983) 0.89

Expression of von Willebrand factor in normal and diseased rat livers and in cultivated liver cells. Hepatology (1995) 0.88

Mechanical restitution during alternans in guinea pig papillary muscles. Cardiovasc Res (1992) 0.88

Distribution and cellular origin of undulin in rat liver. Lab Invest (1992) 0.85

Removal of C6 astrocytoma cell surface molecules with phosphatidylinositol phospholipase C: effect on regulation of neural cell adhesion molecule isoforms. J Neurochem (1991) 0.83

The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans. J Neurosci Res (1992) 0.83

Alternative splicing of neural-cell-adhesion molecule mRNA in human small-cell lung-cancer cell line H69. Int J Cancer (1992) 0.83

Tenascin gene expression in rat liver and in rat liver cells. In vivo and in vitro studies. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.82

Expression of the neural cell adhesion molecule (NCAM) and polysialic acid during taste bud degeneration and regeneration. J Comp Neurol (1994) 0.80

Human dermal microvascular endothelial cells express the 140-kD isoform of neural cell adhesion molecule. Biochem Biophys Res Commun (1994) 0.78

Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression. Int J Cancer (1990) 0.78

Neural cell adhesion molecule is expressed by smooth muscle cells during the development of the rat vascular system. J Neurocytol (1989) 0.78

Expression of N-CAM by human renal cell carcinomas correlates with growth rate and adhesive properties. Exp Cell Res (1994) 0.77

Parenchymal innervation of normal and cirrhotic human liver: a light and electron microscopic study using monoclonal antibodies against the neural cell-adhesion molecule. J Histochem Cytochem (1993) 0.76

Articles by these authors

Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med (1985) 2.84

Possible association between Behçet's syndrome and chronic hepatitis C virus infection. N Engl J Med (1995) 2.83

Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proc Natl Acad Sci U S A (1993) 2.36

Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology (1999) 2.30

Falsely negative 99mTc-antigranulocyte immunoscintigraphy and positive 99mTc-HMPAO-labelled leukocyte scan in active Crohn's disease. Possible effects of immunosuppressive therapy? Nuklearmedizin (1995) 2.00

Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol (1999) 1.89

Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology (1992) 1.78

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology (1998) 1.65

Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol (2000) 1.55

CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol (1997) 1.51

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51

Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication. J Hepatol (1992) 1.51

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology (1997) 1.49

Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver (1999) 1.49

Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol (1999) 1.43

Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol (1997) 1.42

[Initial clinical experiences with TIPS (transjugular intrahepatic portasystemic stent-shunt)]. Leber Magen Darm (1995) 1.40

[Current theraphy of oesophageal cancer]. Z Gastroenterol (2004) 1.39

[Portal hypertension--pathophysiology and therapeutic approaches]. Z Gastroenterol (1994) 1.38

Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol (2000) 1.36

Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol (1985) 1.33

Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology (1995) 1.32

Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology (1999) 1.27

The IGF axis and hepatocarcinogenesis. Mol Pathol (2001) 1.26

Glial fibrillary acidic protein--a cell type specific marker for Ito cells in vivo and in vitro. J Hepatol (1996) 1.23

Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol (1997) 1.19

Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol (1999) 1.18

Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther (1998) 1.17

Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology (1996) 1.17

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol (2001) 1.17

Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J Hepatol (1987) 1.17

The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol (2001) 1.09

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain (1995) 1.09

Dementia and driving. J R Soc Med (1992) 1.04

Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol (2008) 1.03

Localization and mRNA steady-state level of cellular fibronectin in rat liver undergoing a CCl4-induced acute damage or fibrosis. Biochim Biophys Acta (1993) 1.03

The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun (1992) 1.03

High predictability of a sustained virological response (87%) in chronic hepatitis C virus genotype 1 infection treatment by combined IL28B genotype analysis and γ-glutamyltransferase/alanine aminotransferase ratio: a retrospective single-center study. Digestion (2012) 1.03

Liver fibrosis and altered matrix synthesis. Can J Gastroenterol (2001) 1.03

Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate. Biochem J (2000) 1.02

Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC). Carcinogenesis (1998) 1.02

Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology (1993) 1.01

Epidural spinal electrical stimulation for severe angina: a study of its effects on symptoms, exercise tolerance and degree of ischaemia. Eur Heart J (1992) 1.01

Carbohydrate metabolism and the liver: actual aspects from physiology and disease. Z Gastroenterol (2007) 1.01

Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology (1992) 0.99

Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.99

Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1. Exp Cell Res (1997) 0.99

Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci (2001) 0.98

Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. J Hepatol (1997) 0.98

Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol (2001) 0.98

Guillain-Barré syndrome and human diploid cell rabies vaccine. Lancet (1989) 0.97

Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology (1996) 0.97

Decrease of platelet-endothelial cell adhesion molecule 1-gene-expression in inflammatory cells and in endothelial cells in the rat liver following CCl(4)-administration and in vitro after treatment with TNFalpha. Immunol Lett (2000) 0.97

Two management policies for patients after myocardial infarction: Does exercise testing and a more intensive approach make any difference? BMJ (1989) 0.96

Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest (2000) 0.96

HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication? World J Gastroenterol (2001) 0.95

Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types. Z Gastroenterol (2007) 0.95

Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol (1988) 0.95

Synthesis of insulinlike growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor, and growth hormone. Hepatology (1996) 0.94

Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology (1998) 0.94

Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy. World J Gastroenterol (2001) 0.94

Situs inversus of donor or recipient in liver transplantation. Transpl Int (1998) 0.94

Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol (1996) 0.94

Quantitative determination of complement components produced by purified hepatocytes. Clin Exp Immunol (1984) 0.94

Carcinosarcoma of the liver. Histopathology (1998) 0.94

Sinusoidal endothelial liver cells in vitro release endothelin--augmentation by transforming growth factor beta and Kupffer cell-conditioned media. Klin Wochenschr (1991) 0.93

Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio. Dig Dis Sci (1996) 0.93

Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology (1997) 0.93

Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions. J Pathol (2008) 0.92

Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. Am J Emerg Med (1984) 0.92

High inflammatory activity is associated with an increased amount of IFN-gamma transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection. Med Microbiol Immunol (1996) 0.92

The homeobox transcription factor Prox1 is highly conserved in embryonic hepatoblasts and in adult and transformed hepatocytes, but is absent from bile duct epithelium. Anat Embryol (Berl) (2004) 0.92

A reevaluation of the association of hepatitis C virus replicative intermediates with peripheral blood cells including granulocytes by a tagged reverse transcription/polymerase chain reaction technique. J Hepatol (1996) 0.91

Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. Biochem Pharmacol (1999) 0.91

Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol (1998) 0.90

Glucocorticoid receptor signaling in the intestinal epithelial cell lines IEC-6 and Caco-2: evidence of inhibition by interleukin-1beta. Int J Colorectal Dis (2001) 0.90

Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology (2004) 0.90

Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.90

Binding properties of mechanically and enzymatically isolated hepatocytes for IgG and C3. Liver (1983) 0.89

Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol (1999) 0.89

A synthetic glucagon-like peptide-1 analog with improved plasma stability. J Endocrinol (1998) 0.89

Functional characterization of two different Kupffer cell populations of normal rat liver. J Hepatol (1996) 0.89

Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture. Am J Pathol (1999) 0.89

Expression of von Willebrand factor in normal and diseased rat livers and in cultivated liver cells. Hepatology (1995) 0.88